Search for: "Schering Corp" Results 61 - 80 of 252
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
20 Mar 2007, 8:19 am
**Separately**Patently-O notes the Supreme Court has requested the Solicitor General to brief issues in Tamoxifen Citrate Antitrust Litigation, a sequel to the earlier much-discussed Schering Plough case in the 11th Circuit. [read post]
10 Aug 2011, 1:51 pm by Todd Dawson
Posted by Todd DawsonHaving already struck out on a curveball they thought was a fastball over the middle of the plate, Schering Corp. [read post]
15 Aug 2011, 6:01 am by Rebecca Tushnet
Schering-Plough Corp., 2011 WL 3452398 (Cal.App. 2 Dist.) [read post]
31 Aug 2007, 12:53 am
Schering-Plough Defends Suits Over Marketing of 'Off-Label' Drug Uses New Jersey Law Journal Schering-Plough Corp. faces a spate of federal court litigation over promotion of its drugs for uses not approved by the Food and Drug Administration. [read post]
23 Jan 2013, 4:16 pm by Lawrence B. Ebert
Schering-Plough Corp., 320 F.3d 1339, 1345 (Fed.Cir. 2003). [read post]
22 Feb 2009, 8:38 pm
Patent No. 5,807,825 ("Platelet Aggregation Inhibitors," issued September 15, 1998), licensed to Schering Corp., following a Paragraph IV certification as part of Teva's filing of an ANDA to manufacture a generic version of Schering-Plough's Integrilin ® (eptifibatide injection, used to treat acute coronary syndrome). [read post]
1 May 2009, 8:25 am
SEC Investigating Schering-Plough Trades: The SEC is investigating trading of Schering-Plough shares ahead of the announcement of its merger with Merck & Co., people familiar with the matter said. [read post]
8 May 2012, 6:31 pm by Lawrence B. Ebert
” Id. at 1337 (quoting Schering Corp. v. [read post]
24 May 2011, 2:09 pm by Jenna Greene
Court of Appeals for the Third Circuit, involves a settlement between Schering-Plough Corp., which owned a key patent (now expired) for the high blood pressure medication K-Dur 20, and generic drug makers Upsher Smith and ESI (formerly a division of Wyeth). [read post]
11 Mar 2011, 8:09 am by Keith Reinfeld
On February 28, 2011, the United States Supreme Court denied the petition by Novartis and Schering Corp. to review the decision. [read post]
15 Jan 2008, 12:02 am
Plaintiffs Lawyers Split $9.5M Fee in Shareholder Suit Against Schering-Plough New Jersey Law Journal A federal judge approved a settlement Monday in a shareholders' derivative suit against Schering-Plough Corp. with no award of damages but a $9.5 million fee to plaintiffs counsel and a company pledge to reform its governance. [read post]
31 Aug 2007, 1:35 am
" Schering-Plough Defends Suits Over Marketing of 'Off-Label' Drug Uses "Schering-Plough Corp. faces a spate of federal court litigation over promotion of its drugs for uses not approved by the Food and Drug Administration. [read post]
8 Jan 2018, 3:34 pm by Lawrence B. Ebert
Moreover, extrinsic evidence need not antedatethe critical date of the patent at issue, Schering Corp. v.Geneva Pharm., Inc., 339 F.3d 1373, 1377 (Fed. [read post]
22 Apr 2011, 10:51 am by Zoe Tillman
Merck merged with Schering-Plough Corp. on Nov. 3, 2009, and, according to the complaint, had told PETA that they needed to prove ownership in Schering-Plough to be eligible. [read post]
14 Mar 2011, 9:25 pm by D. Maimon Kirschenbaum
Two pharmaceutical giants - Novartis Pharmaceuticals and Schering Corp - may have exhausted their legal remedies to fight the Second Circuit's decision. [read post]